fig6
From: Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma
![Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma](https://image.oaes.cc/fbb06c61-f02a-4138-a742-4ae4f2014e4d/3128.fig.6.jpg)
Figure 6. Effect of chemoresistance on glycine isotopomer ratios. A: Model depicting the pathway for glycine M1 and M2 isotopomer production from U-13C glucose; B: Glycine M1:M2 isotopomer ratios in BCNU-sensitive (9L-S) and BCNU-resistant (9L-R) glioma cells in the absence and presence of 40 mM DCA. Bars (mean ± SD) with different letters are significantly different from each other at P ≤ 0.05